Infected Diabetic Foot Ulcer on Siddha External Therapy
A 60-year-old man with type 2 diabetes for 12 years has a non-healing ulcer on the right great toe. It measures 3 by 2 cm and has a foul smell. Surrounding erythema extends about 4 cm, and the tissue is warm and tender. A probe reaches bone. His HbA1c is 9.8%, fasting glucose 210 mg/dL, and he has reduced sensation in the foot. He has been applying Thirumeni thailam externally and drinking Madhumeha kudineer for two months. He refuses hospital admission because he believes the Siddha oil is drawing out the poison. He has no fever, but his white cell count is 13,500/µL. Dorsalis pedis pulsation is weak. He asks whether he should increase the oil application and continue the kudineer alone.
1. How would you classify this ulcer, and why is continuing the current plan unsafe?
Read the worked answer
This is a deep, infected diabetic foot ulcer with possible osteomyelitis, given the probe-to-bone finding, foul smell, surrounding cellulitis, raised white cell count, and poor glycaemic control. Weak pedal pulses suggest peripheral arterial disease, which further impairs healing. Continuing only external Thirumeni thailam and Madhumeha kudineer is unsafe because the oil can macerate the skin, obscure the wound, and delay debridement, while the infection and bone involvement need urgent medical and surgical assessment. In Siddha terms, the ulcer may be interpreted as a chronic vatha-kabam lesion with impaired tissue nutrition, but that interpretation does not remove the need for infection control. The correct judgement is that topical therapy must not be intensified and oral Siddha medicine alone is insufficient. Delay risks spreading infection, gangrene, and amputation.
2. Outline the referral and management plan you would recommend, including the role of Siddha treatment after infection control.
Read the worked answer
Refer urgently for diabetic foot assessment: wound swab or deep tissue culture, plain radiograph or MRI to assess bone, vascular assessment, and surgical debridement. Start empirical antibiotics according to local protocol after cultures, and optimise glycaemic control, possibly with insulin. Stop the external oil until the wound is clean and under specialist care. The Madhumeha kudineer should not be relied on as the sole treatment; if continued, disclose it to the treating team because herb-drug interactions and glucose-lowering effects must be monitored. After infection is controlled and debridement is complete, a qualified Siddha practitioner may consider adjunctive wound care and internal medicine, with clear documentation and shared monitoring. Counsel the patient that preserving the foot requires urgent hospital care, not stronger oil application. The key reasoning is that deep infection and possible osteomyelitis are time-critical and cannot be managed by topical Siddha therapy alone.